Jasmine Kway - Apr 7, 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: CEO - Singapore Volition
Signature: /s/ Jasmine Kway
Stock symbol: VNRX
Transactions as of: Apr 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/8/2022, 04:01 PM
Previous filing: Dec 10, 2021
Next filing: Jun 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNRX	Common Stock	Award	$0	+9.6K		$0.00	9.6K	Apr 7, 2022	Direct	F1
holding	VNRX	Common Stock						5.4K	Apr 7, 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Award	$0	+17.7K		$0.00	17.7K	Apr 7, 2022	Common Stock	17.7K	$3.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 3, 2021, the reporting person was awarded 27,440 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,604 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 4,802 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F2	On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,698 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 8,849 shares on each of August 3, 2022 and August 3, 2023, respectively.

Content

On August 3, 2021, the reporting person was awarded 27,440 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,604 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 4,802 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,698 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 8,849 shares on each of August 3, 2022 and August 3, 2023, respectively.